These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pitavastatin: an overview. Saito Y Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281 [TBL] [Abstract][Full Text] [Related]
3. Pitavastatin: a new HMG-CoA reductase inhibitor. Wensel TM; Waldrop BA; Wensel B Ann Pharmacother; 2010 Mar; 44(3):507-14. PubMed ID: 20179258 [TBL] [Abstract][Full Text] [Related]
4. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin. da Silva PM Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776 [TBL] [Abstract][Full Text] [Related]
6. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus. Kawai Y; Sato-Ishida R; Motoyama A; Kajinami K Drug Des Devel Ther; 2011; 5():283-97. PubMed ID: 21625418 [TBL] [Abstract][Full Text] [Related]
7. Pitavastatin - from clinical trials to clinical practice. Masana L Atheroscler Suppl; 2010 Dec; 11(3):15-22. PubMed ID: 21193154 [TBL] [Abstract][Full Text] [Related]
8. Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia. Ahmad H; Cheng-Lai A Cardiol Rev; 2010; 18(5):264-7. PubMed ID: 20699675 [TBL] [Abstract][Full Text] [Related]
9. Pitavastatin: efficacy and safety in intensive lipid lowering. Hayashi T; Yokote K; Saito Y; Iguchi A Expert Opin Pharmacother; 2007 Oct; 8(14):2315-27. PubMed ID: 17927486 [TBL] [Abstract][Full Text] [Related]
13. Pitavastatin improves plasma pentraxin 3 and arterial stiffness in atherosclerotic patients with hypercholesterolemia. Ohbayashi H; Miyazawa C; Miyamoto K; Sagara M; Yamashita T; Onda R J Atheroscler Thromb; 2009 Aug; 16(4):490-500. PubMed ID: 19729861 [TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular prevention and pitavastatin]. Kayıkçıoğlu M Turk Kardiyol Dern Ars; 2017 Apr; 45(Suppl 3):8-12. PubMed ID: 28952472 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on the lipid and pleiotropic effects of pitavastatin. Sahebkar A; Kiaie N; Gorabi AM; Mannarino MR; Bianconi V; Jamialahmadi T; Pirro M; Banach M Prog Lipid Res; 2021 Nov; 84():101127. PubMed ID: 34509516 [TBL] [Abstract][Full Text] [Related]
16. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication. Yee LL; Wright EA Clin Ther; 2011 Aug; 33(8):1023-42. PubMed ID: 21816477 [TBL] [Abstract][Full Text] [Related]
17. New evidence on pitavastatin: efficacy and safety in clinical studies. Teramoto T; Shimano H; Yokote K; Urashima M Expert Opin Pharmacother; 2010 Apr; 11(5):817-28. PubMed ID: 20201733 [TBL] [Abstract][Full Text] [Related]
18. Pitavastatin: A Review in Hypercholesterolemia. Hoy SM Am J Cardiovasc Drugs; 2017 Apr; 17(2):157-168. PubMed ID: 28130659 [TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia. Nakagomi A; Shibui T; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W J Atheroscler Thromb; 2015; 22(11):1158-71. PubMed ID: 26084792 [TBL] [Abstract][Full Text] [Related]
20. The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C. Teramoto T Expert Opin Pharmacother; 2012 Apr; 13(6):859-65. PubMed ID: 22332608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]